Novartis treatment of active tuberculosis granted orphan drug status Novartis' Lamprene was granted orphan drug designation as a treatment of active tuberculosis, according to a post to the FDA's website. Reference Link
News For NVS From The Last 14 Days
Check below for free stories on NVS the last two weeks.
Novartis treatment for pigmented villonodular synovitis gets orphan designation According to a post on the FDA's website, Novartis' recombinant human monoclonal antibody of the IgG1 kappa class against human macrophage colony-stimulating factor received orphan designation. Reference Link